| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/11/1994 | US5277904 Broad spectrum dermatophyte vaccine |
| 01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
| 01/11/1994 | CA1326109C Sv40 expression vector containing hbxag as an expression marker |
| 01/06/1994 | WO1994000601A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/06/1994 | WO1994000596A1 Acceptor for fucosyltransferase |
| 01/06/1994 | WO1994000590A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/06/1994 | WO1994000586A2 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 01/06/1994 | WO1994000575A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | WO1994000562A1 A novel human immunodeficiency virus |
| 01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
| 01/06/1994 | WO1994000557A1 Method for preparing membrane proteins and preserving their oligomeric structures under denaturing conditions, and uses of said proteins in diagnostics and vaccination |
| 01/06/1994 | WO1994000556A1 Fusobacterium necrophorum leukotoxoid vaccine |
| 01/06/1994 | WO1994000555A2 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | WO1994000494A1 Improvements in or relating to neuroregeneration |
| 01/06/1994 | WO1994000493A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | WO1994000491A1 INTERLEUKIN-1β DELETION MUTANT |
| 01/06/1994 | WO1994000487A1 Peptide which produces protective immunity against tetanus |
| 01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | WO1994000475A1 N-acetylglucosaminyltransferase v coding sequences |
| 01/06/1994 | WO1994000154A1 DNA ENCODING PRECURSOR INTERLEUKIN 1β CONVERTING ENZYME |
| 01/06/1994 | WO1994000153A1 Vaccine composition containing adjuvants |
| 01/06/1994 | WO1994000151A1 Combinatorial polypeptide antigens |
| 01/06/1994 | WO1994000150A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 01/06/1994 | WO1994000149A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000136A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 01/06/1994 | WO1994000112A1 An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
| 01/06/1994 | WO1993021331A3 Polysaccharide binding fusion proteins and conjugates |
| 01/06/1994 | WO1993016726A3 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | CA2138996A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 01/06/1994 | CA2138970A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2137008A1 Acceptor for fucosyltransferase |
| 01/06/1994 | CA2136981A1 Dna encoding precursor interleukin 1.beta. converting enzyme |
| 01/06/1994 | CA2120745A1 A combination of anti-erbb-2 monoclonal antibodies and method of using |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/05/1994 | EP0577458A1 Nucleotide and Peptide sequences of the FIV isolate WO and their uses in diagnostic and prevention of the feline immunodeficiency virus infection |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0577225A1 Diagnosis and treatment of inflammation |
| 01/05/1994 | EP0577224A1 Bacterial antigens, antibodies, vaccines and methods of manufacture |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0576522A1 A single dose vaccination system |
| 01/05/1994 | EP0576471A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 01/05/1994 | EP0576439A1 Monoclonal antibody against lps core |
| 01/05/1994 | DE4221840A1 Bivalente Lebendvakazine gegen bakterielle Darmpathogene, Herstellungsverfahren sowie Plasmide und Stämme als Ausgangsmaterial Bivalent Lebendvakazine against bacterial enteric pathogens, production processes, and plasmids and strains as starting material |
| 01/05/1994 | CN1080189A Small-dose inactivated vaccine |
| 01/04/1994 | US5276494 High-speed printing device having a particle trap arranged in the paper channel |
| 01/04/1994 | US5276142 Vaccines |
| 01/04/1994 | US5276016 Alleviates aids symptoms |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275947 Non-A, non-B hepatitis virus antigen peptide |
| 01/04/1994 | US5275934 Method of detecting viral infection in vaccinated animals |
| 01/04/1994 | US5275814 Allergen-thymic hormone conjugates for treatment of IgE mediated allergies |
| 01/04/1994 | US5275813 Methods and compositions for vaccinating against feline immunodeficiency virus |
| 01/04/1994 | CA2099531A1 Monoclonal antibodies to hiv-1 gp120, cell lines producing them, preparations for passive immunotherapy, vaccines containing corresponding epitope structures and process for preparing these antibodies |
| 12/29/1993 | EP0576092A1 Recombinant Feline herpesvirus vaccine |
| 12/29/1993 | EP0575559A1 TGF-$g(b)1/$g(b)2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 12/29/1993 | EP0575556A1 Palytoxin-related prodrugs and a method for their administration |
| 12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
| 12/29/1993 | EP0575544A1 Malaria recombinant poxvirus vaccine |
| 12/29/1993 | EP0575539A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 12/29/1993 | EP0575517A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575407A1 Humanised antibodies having modified allotypic determinants |
| 12/29/1993 | EP0575348A1 FLAGELLA-LESS $i(BORRELIA) |
| 12/29/1993 | EP0575321A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
| 12/29/1993 | EP0575311A1 Control of secretion of milk |
| 12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
| 12/29/1993 | EP0396549B1 A drug composition with microspheres and process for its preparation |
| 12/29/1993 | EP0375743B1 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 12/29/1993 | EP0192671B1 Minactivin |
| 12/29/1993 | CN1079908A Histamine derivatives and methods for their use as immunomodulators |
| 12/29/1993 | CN1023295C Method and composition for prophylaxis and treatment of viral infections |
| 12/28/1993 | US5274081 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
| 12/28/1993 | US5274076 N-alpha-acetyl,N-epsilon(histamine-succinyl-glycl)-L-lysyl-L -tyrosyl-N-epsilon(histamine-succinyl-glycyl)-L-lysylamide |
| 12/28/1993 | US5274075 Newly identified human epsilon immunoglobulin peptides and related products |
| 12/28/1993 | US5273965 A reduced and hydrolyzed saponin from a Quillaja saponaria extract |
| 12/28/1993 | US5273963 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 12/28/1993 | US5273901 Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
| 12/28/1993 | US5273889 Gamma-iterferon-leukotoxin gene fusions and uses thereof |
| 12/28/1993 | US5273884 Polypetides, antigens or vaccines protective against babesiosis |
| 12/28/1993 | US5273745 Virus-modified tumor vaccines for immunotherapy of tumor metastases |
| 12/28/1993 | US5273744 A pure and antigenic polypeptide for cattle immunity |
| 12/28/1993 | CA1325612C Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 12/28/1993 | CA1325611C Heliothis expression systems |
| 12/28/1993 | CA1325594C Agents for the prophylaxis and therapy of retroviral infections |
| 12/28/1993 | CA1325592C Use of antigenic substances for the prophylaxis or therapy of disorders and diseases within the gastrointestinal tract of animals and humans |
| 12/28/1993 | CA1325591C Method for treating malignancy and autoimmune disorders in humans |
| 12/23/1993 | WO1993025700A1 Monoclonal antibodies to glycoprotein p |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025690A1 Recombinant pseudomonas exotoxin with increased activity |
| 12/23/1993 | WO1993025689A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 12/23/1993 | WO1993025688A1 Recombinant production of saporin-containing proteins |
| 12/23/1993 | WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 12/23/1993 | WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |